Mitochondrial fatty acid uptake and complex IV inhibition by palmitoylcarnitine in early type-2 diabetic hearts. by Phing-How Lou (198977)

“…N = 5–6 hearts per group. Data are or mean ± SD (panels A) or mean ± SEM (panel B).</p>…”

The probability of tumor nodule eradication increases with the increase of CTL number. by Claire Christophe (714134)

“…Other lines: same evolution when the mean killing time is decreased by 10%, 50% and 90%. …”

Overexpression of miR-105 inhibits tumour cell growth but does not induce apoptosis. by D. Rice Honeywell (442714)

“…<p>(A–B) Tumour cells were transfected with either 50 nM miR-105 (closed squares) or control (open circles) mimics and subsequently seeded into 96-well plates in replicates of 8. …”

Presentation1.ppt by Julien Leuthold (4921660)

“…We show that partial resorption textures and geochemical zoning result from partial melting of REE-poor lower oceanic crust gabbroic cumulate (protolith) following intrusion by hot primitive mantle-derived melt, and subsequent overgrowth crystallization (refertilization) from a hybrid melt. …”

Table1.xlsx by Julien Leuthold (4921660)

“…We show that partial resorption textures and geochemical zoning result from partial melting of REE-poor lower oceanic crust gabbroic cumulate (protolith) following intrusion by hot primitive mantle-derived melt, and subsequent overgrowth crystallization (refertilization) from a hybrid melt. …”

Image1.JPEG by Julien Leuthold (4921660)

“…We show that partial resorption textures and geochemical zoning result from partial melting of REE-poor lower oceanic crust gabbroic cumulate (protolith) following intrusion by hot primitive mantle-derived melt, and subsequent overgrowth crystallization (refertilization) from a hybrid melt. …”

Table4.XLSX by Julien Leuthold (4921660)

“…We show that partial resorption textures and geochemical zoning result from partial melting of REE-poor lower oceanic crust gabbroic cumulate (protolith) following intrusion by hot primitive mantle-derived melt, and subsequent overgrowth crystallization (refertilization) from a hybrid melt. …”

Table2.xlsx by Julien Leuthold (4921660)

“…We show that partial resorption textures and geochemical zoning result from partial melting of REE-poor lower oceanic crust gabbroic cumulate (protolith) following intrusion by hot primitive mantle-derived melt, and subsequent overgrowth crystallization (refertilization) from a hybrid melt. …”

Table3.XLSX by Julien Leuthold (4921660)

“…We show that partial resorption textures and geochemical zoning result from partial melting of REE-poor lower oceanic crust gabbroic cumulate (protolith) following intrusion by hot primitive mantle-derived melt, and subsequent overgrowth crystallization (refertilization) from a hybrid melt. …”

Image4.jpg by Julien Leuthold (4921660)

“…We show that partial resorption textures and geochemical zoning result from partial melting of REE-poor lower oceanic crust gabbroic cumulate (protolith) following intrusion by hot primitive mantle-derived melt, and subsequent overgrowth crystallization (refertilization) from a hybrid melt. …”

Image2.JPEG by Julien Leuthold (4921660)

“…We show that partial resorption textures and geochemical zoning result from partial melting of REE-poor lower oceanic crust gabbroic cumulate (protolith) following intrusion by hot primitive mantle-derived melt, and subsequent overgrowth crystallization (refertilization) from a hybrid melt. …”

Image3.jpg by Julien Leuthold (4921660)

“…We show that partial resorption textures and geochemical zoning result from partial melting of REE-poor lower oceanic crust gabbroic cumulate (protolith) following intrusion by hot primitive mantle-derived melt, and subsequent overgrowth crystallization (refertilization) from a hybrid melt. …”

Image2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Image1_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Table4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Image3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Table3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Image4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Table2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Table1_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”